206 related articles for article (PubMed ID: 35837069)
1. Inhibition of cell survival and invasion by Tanshinone IIA via FTH1: A key therapeutic target and biomarker in head and neck squamous cell carcinoma.
Mao W; Ding J; Li Y; Huang R; Wang B
Exp Ther Med; 2022 Aug; 24(2):521. PubMed ID: 35837069
[TBL] [Abstract][Full Text] [Related]
2. Ferroptosis Driver
Hu ZW; Wen YH; Ma RQ; Chen L; Zeng XL; Wen WP; Sun W
Front Cell Dev Biol; 2021; 9():727762. PubMed ID: 34527677
[TBL] [Abstract][Full Text] [Related]
3. FTH1 indicates poor prognosis and promotes metastasis in head and neck squamous cell carcinoma.
Liao Q; Yang J; Lu Z; Jiang Q; Gong Y; Liu L; Peng H; Wang Q; Zhang X; Liu Z
PeerJ; 2023; 11():e16493. PubMed ID: 38025726
[TBL] [Abstract][Full Text] [Related]
4. SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1.
Xu X; Mao Y; Feng Z; Dai F; Gu T; Zheng J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186303
[TBL] [Abstract][Full Text] [Related]
5. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
PeerJ; 2023; 11():e16237. PubMed ID: 37842043
[TBL] [Abstract][Full Text] [Related]
6. HSPA5, as a ferroptosis regulator, may serve as a potential therapeutic for head and neck squamous cell carcinoma.
Li J; Xiao W; Wei W; Wu M; Xiong K; Lyu J; Li Y
Mol Immunol; 2023 Jun; 158():79-90. PubMed ID: 37172353
[TBL] [Abstract][Full Text] [Related]
7. Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1.
Wen Z; Zhang Y; Gao B; Chen X
J Gene Med; 2024 Feb; 26(2):e3669. PubMed ID: 38380717
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel hub genes associated with lymph node metastasis of head and neck squamous cell carcinoma by completive bioinformatics analysis.
Lu H; Li L; Sun D; Duan Y; Yue K; Wu Y; Wang X
Ann Transl Med; 2021 Nov; 9(22):1678. PubMed ID: 34988187
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 promotes cancer progression via inhibiting ferroptosis in head and neck squamous cell carcinoma.
Lu T; Zhang Z; Pan X; Zhang J; Wang X; Wang M; Li H; Yan M; Chen W
J Oral Pathol Med; 2022 Jan; 51(1):52-62. PubMed ID: 34874578
[TBL] [Abstract][Full Text] [Related]
11. Combination RSL3 Treatment Sensitizes Ferroptosis- and EGFR-Inhibition-Resistant HNSCCs to Cetuximab.
Liu S; Yan S; Zhu J; Lu R; Kang C; Tang K; Zeng J; Ding M; Guo Z; Lai X; Jiang Y; Wu S; Zhou L; Sun L; Zhou ZW
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012290
[TBL] [Abstract][Full Text] [Related]
12. A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.
Xu L; Li YY; Zhang YC; Wu YX; Guo DD; Long D; Liu ZH
Dis Markers; 2021; 2021():5759927. PubMed ID: 34853622
[TBL] [Abstract][Full Text] [Related]
13. Risk model-guided identification of MTDH expression as a marker for ferroptosis induction therapy in head and neck squamous cell carcinoma.
Wang X; Gao Y; Miao R; Li L; Nanding A; Liu Y; Zhang X
Am J Cancer Res; 2023; 13(11):5236-5253. PubMed ID: 38058815
[TBL] [Abstract][Full Text] [Related]
14. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J
J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034
[TBL] [Abstract][Full Text] [Related]
15. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
16. A Ferroptosis-Related Gene Signature for Predicting the Prognosis and Drug Sensitivity of Head and Neck Squamous Cell Carcinoma.
Lu W; Wu Y; Huang S; Zhang D
Front Genet; 2021; 12():755486. PubMed ID: 34745224
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck.
Li C; Wang X; Qin R; Zhong Z; Sun C
Front Genet; 2021; 12():698040. PubMed ID: 34539737
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Zhang YY; Mao MH; Han ZX
Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
[TBL] [Abstract][Full Text] [Related]
20. Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis.
Li CY; Cai JH; Tsai JJP; Wang CCN
Front Oncol; 2020; 10():681. PubMed ID: 32528874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
